semaglutide and cushing's Spotlight on the Mechanism of Action of Violaceous abdominal striae noted on

Understanding the real difference between semaglutide and liraglutide requires going beyond surface-level comparisons

Medicijnen kunnen helpen, maar als je ernstig overgewicht hebt, is dat vaak niet genoeg om voldoende gewicht te verliezen en op de lange termijn op gewicht te blijven. Een nuchtere constatering, maar wel een juiste

Exceptional safety margin No dependence or tolerance naturally occurring endogenous peptide Tolerability in clinical trials No tolerance develops with repeated doses No withdrawal symptoms upon stopping Peptide naturally present in the human body Research considerations Researcher's notes Outstanding safety profile for a bioactive peptide No serious adverse events were reported in the published studies

References and Further Reading: Tongta, S., Sungkaworn, T., & Pathomthongtaweechai, N

38 Ertugliflozin EMA product information (2023)